News for 'COV'

'Everybody need not rush to hospital'

'Everybody need not rush to hospital'

Rediff.com7 Jan 2022

'If your oxygen saturation is okay and is maintained after the six-minute walk test -- which has been described all over the world -- and you do not have an unrelenting fever, then you can even be managed at home.'

No case of new variant detected at Delhi airport: Lab

No case of new variant detected at Delhi airport: Lab

Rediff.com27 Nov 2021

The Centre had on Thursday asked all states and union territories to conduct rigorous screening and testing of all international travellers coming from or transiting through South Africa, Hong Kong and Botswana, where the B.1.1.529 variant has been detected.

Coronavirus mutations may not make it more infectious: Study

Coronavirus mutations may not make it more infectious: Study

Rediff.com26 May 2020

Coronaviruses, like other RNA viruses, can develop mutations in three different ways: by mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell, or they can be induced by RNA modification systems which are part of host immunity, the researchers explained.

India-US coalition begin clinical trials for coronavirus

India-US coalition begin clinical trials for coronavirus

Rediff.com17 Mar 2020

The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.

New Omicron sub-variant detected in countries like India: WHO

New Omicron sub-variant detected in countries like India: WHO

Rediff.com7 Jul 2022

A new sub-lineage BA.2.75 of the Omicron variant of the coronavirus has been detected in countries like India and the World Health Organisation is following this, Director-General Tedros Adhanom Ghebreyesus said.

Six feet gap not enough to prevent virus spread, says study

Six feet gap not enough to prevent virus spread, says study

Rediff.com15 Sep 2021

Physical distancing of two metres - about six and a half feet - may not be enough to sufficiently prevent transmission of virus-carrying airborne aerosols indoors, says a study.

IIT study finds Covid traces in Sabarmati river, 2 lakes

IIT study finds Covid traces in Sabarmati river, 2 lakes

Rediff.com18 Jun 2021

A recent study by researchers at the Indian Institute of Technology (IIT) Gandhinagar has established the presence of coronavirus in water samples from the Sabarmati river and two lakes in Ahmedabad city of Gujarat.

New rules: No Covid test for kids arriving from abroad

New rules: No Covid test for kids arriving from abroad

Rediff.com11 Nov 2021

Children below five years are exempted from both pre- and post-arrival testing for COVID-19 in India, according to the revised guidelines for international arrivals released on Thursday.

'Dengue outbreak may aggravate COVID-19 crisis'

'Dengue outbreak may aggravate COVID-19 crisis'

Rediff.com10 Jul 2020

The impact of a 'dengue-COVID-19' season would entail two different diagnostic tests and extract a huge toll on patients too, each disease making the other more complicated to deal with and perhaps more fatal.

'UK strain behind current COVID surge in Delhi'

'UK strain behind current COVID surge in Delhi'

Rediff.com23 Apr 2021

According to the NCDC, 415 cases of the UK strain of coronavirus were found in genomes sequenced in Delhi, followed by 23 cases of the South African strain.

Covid vaccines for children likely by Sept: AIIMS chief

Covid vaccines for children likely by Sept: AIIMS chief

Rediff.com24 Jul 2021

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

'The severe cases are mostly unvaccinated people'

'The severe cases are mostly unvaccinated people'

Rediff.com28 Dec 2021

'In our ICUs, the majority are unvaccinated people.' 'Out of the hospital, in the community, we see that -- whether you are vaccinated or whether you're not vaccinated -- the symptoms are more or less the same.'

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

Rediff.com25 Sep 2021

Prime Minister Narendra Modi, in his address at the 76th session of the United Nations General Assembly on Saturday, invited the global manufacturers of vaccines to come and make vaccines in India, stressing that the country's "faith is to serve people".

Tata Trusts, private firm join hands to roll out coronavirus testing kits

Tata Trusts, private firm join hands to roll out coronavirus testing kits

Rediff.com8 Apr 2020

The test - called the Truenat Beta CoV test - effectively enables same-day testing, reporting, and patient isolation initiation.

Covid Delta variant behind bulk of breakthrough infections in India

Covid Delta variant behind bulk of breakthrough infections in India

Rediff.com20 Aug 2021

Breakthrough infections of coronavirus cases comprise a very high proportion of the Delta variant, the INSACOG, a genome sequencing government consortium of laboratories, has said.

66% adults given at least one COVID-19 vaccine jab: Govt

66% adults given at least one COVID-19 vaccine jab: Govt

Rediff.com23 Sep 2021

Addressing a press conference, Union health secretary Rajesh Bhushan said 63.7 per cent vaccine doses have been administered in rural areas and 35.4 per cent in urban areas.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Rediff.com20 Sep 2021

Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11 years, and they plan to seek regulatory approvals as soon as possible.

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

First Covid case may have emerged in China in Oct 2019: Study

First Covid case may have emerged in China in Oct 2019: Study

Rediff.com25 Jun 2021

The research, published in the journal PLOS Pathogens on Thursday, suggests that the first case of COVID-19 arose between early October and mid-November, 2019 in China, with the most likely date of origin being November 17.

Maha to issue revised air travel guidelines 'in a couple of days'

Maha to issue revised air travel guidelines 'in a couple of days'

Rediff.com2 Dec 2021

Tope's comments came a day after the Centre asked the state to align its order with the SOPs issued by the Union health ministry.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

Too early to do away with face masks: Experts

Too early to do away with face masks: Experts

Rediff.com1 Apr 2022

The country saw a reduction in the number of swine flu cases due to masks and sanitation practices.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Nortje out of quarantine after false COVID-19 scare

Nortje out of quarantine after false COVID-19 scare

Rediff.com16 Apr 2021

The Proteas speedster, a star performer for DC in the last edition, had tested positive for COVID-19 while in quarantine. But was retested and came out negative in three RT-PCR results.

Vaccines will work against new COVID-19 variant: Govt

Vaccines will work against new COVID-19 variant: Govt

Rediff.com29 Dec 2020

'Most vaccines do target the Spike protein, in which there are changes in the variants but vaccines stimulate our immune system to produce a wide range of protective antibodies'

Mumbai, Delhi, Guj report big spike in new Covid cases

Mumbai, Delhi, Guj report big spike in new Covid cases

Rediff.com29 Dec 2021

The spike in the country's financial capital has got pronounced since December 20, when just 283 cases were reported. Tuesday had witnessed 1,377 cases in the metropolis, and Wednesday's figure was a jump by over 80 per cent, he pointed out.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

Breakthrough Covid infections in India within expected numbers: INSACOG

Breakthrough Covid infections in India within expected numbers: INSACOG

Rediff.com1 Sep 2021

When a person gets an infection even after being vaccinated against it, it is called a breakthrough case.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Covid deaths could touch 1 million by August: Lancet

Covid deaths could touch 1 million by August: Lancet

Rediff.com8 May 2021

If that outcome were to happen, the Modi government would be responsible for presiding over a self-inflicted national catastrophe.

USFDA denies Covaxin emergency use nod, to take 'full approval' route

USFDA denies Covaxin emergency use nod, to take 'full approval' route

Rediff.com11 Jun 2021

In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.

Coronavirus can last on face masks for a week: Study

Coronavirus can last on face masks for a week: Study

Rediff.com6 Apr 2020

'If you want to protect yourself just maintain good hygiene, wash your hands often and try not to touch your face, your mouth or nose without cleaning first'

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

Unplanned vaccination can promote mutant strains: Experts to PM

Unplanned vaccination can promote mutant strains: Experts to PM

Rediff.com10 Jun 2021

A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

Omicron overtakes Delta; less severe but not mild: WHO

Omicron overtakes Delta; less severe but not mild: WHO

Rediff.com12 Jan 2022

"Omicron has been detected in all countries where we have good sequencing and it's likely to be in all countries around the world. It is quickly, in terms of its circulation, overtaking Delta. And so Omicron is becoming the dominant variant that is being detected," Kerkhove said during a virtual questions and answers session.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.